Allianz Asset Management GmbH Has $96.71 Million Position in Agilent Technologies, Inc. $A

Allianz Asset Management GmbH lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 20.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 753,449 shares of the medical research company’s stock after selling 192,440 shares during the quarter. Allianz Asset Management GmbH’s holdings in Agilent Technologies were worth $96,705,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Norges Bank acquired a new stake in Agilent Technologies in the second quarter valued at approximately $395,088,000. AQR Capital Management LLC raised its position in shares of Agilent Technologies by 424.1% during the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after purchasing an additional 1,652,244 shares during the period. Ameriprise Financial Inc. lifted its holdings in shares of Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after purchasing an additional 1,340,161 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in Agilent Technologies by 10.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after purchasing an additional 1,273,994 shares during the period. Finally, Troy Asset Management Ltd increased its stake in Agilent Technologies by 74.3% during the 2nd quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock valued at $282,967,000 after purchasing an additional 1,021,865 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. The Goldman Sachs Group assumed coverage on shares of Agilent Technologies in a research note on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price objective on the stock. Wells Fargo & Company raised their price target on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Barclays raised Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 price objective for the company in a report on Monday, December 15th. Evercore ISI upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and raised their target price for the company from $155.00 to $160.00 in a report on Monday, January 5th. Finally, Citigroup lifted their target price on Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $164.50.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 911 shares of the business’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the sale, the chief executive officer directly owned 32,058 shares in the company, valued at $4,591,987.92. The trade was a 2.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the transaction, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. The trade was a 8.61% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 16,401 shares of company stock valued at $2,468,962 over the last three months.

Agilent Technologies Trading Down 2.4%

NYSE A opened at $132.08 on Wednesday. The business’s fifty day moving average is $141.36 and its 200-day moving average is $134.95. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The stock has a market capitalization of $37.44 billion, a price-to-earnings ratio of 28.90, a PEG ratio of 3.93 and a beta of 1.30. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th were paid a $0.255 dividend. The ex-dividend date was Tuesday, January 6th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.32%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.